Log in

Relevant bibliographies by topics / Microalbuminurie / Journal articles

To see the other types of publications on this topic, follow the link: Microalbuminurie.

Journal articles on the topic 'Microalbuminurie'

Author: Grafiati

Published: 4 June 2021

Last updated: 3 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Microalbuminurie.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Fonfrede, Michèle. "Microalbuminurie." EMC - Biologie Médicale 1, no. 1 (2006): 1–5. http://dx.doi.org/10.1016/s2211-9698(06)76096-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Knebelmann, B. "Microalbuminurie : définitions et intérêt Place du rapport microalbuminurie/créatininurie." Bio Tribune Magazine 18, no. 1 (2006): 12–14. http://dx.doi.org/10.1007/bf03001357.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

A, F. "Empagliflozine et microalbuminurie." Médecine des Maladies Métaboliques 10, no. 6 (2016): 583. http://dx.doi.org/10.1016/s1957-2557(16)30178-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

A, F. "Équilibre tensionnel et microalbuminurie." Médecine des Maladies Métaboliques 10, no. 7 (2016): 677. http://dx.doi.org/10.1016/s1957-2557(16)30199-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Zaoui, Philippe. "Microalbuminurie et charge sodée." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2004, no. 132 (2004): 10. http://dx.doi.org/10.1016/s1261-694x(04)73434-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Roger, Christelle, and Marie-Christine Carlier. "Albuminurie, microalbuminurie et diabète." Revue Francophone des Laboratoires 2018, no. 502 (2018): 44–47. http://dx.doi.org/10.1016/s1773-035x(18)30147-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mekideche, F., F. Z. Mekideche, R. Chermat, and R. Malek. "P64 Microalbuminurie et syndrome métabolique." Diabetes & Metabolism 35 (March 2009): A43. http://dx.doi.org/10.1016/s1262-3636(09)71862-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Guieu, R., and C. Monserrat. "Microalbuminurie : méthodes de dosage et interprétation." EMC - Traité de médecine AKOS 4, no. 4 (2009): 1–4. http://dx.doi.org/10.1016/s1634-6939(09)48424-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

James, M. A., M. D. Fotherby, and J. F. Potter. "Screening Tests for Microalbuminuria in Non-Diabetic Elderly Subjects and Their Relation to Blood Pressure." Clinical Science 88, no. 2 (1995): 185–90. http://dx.doi.org/10.1042/cs0880185.

Full text

Abstract:

1. Microalbumuria in non-diabetic elderly subjects is predictive of vascular disease and mortality, and related to levels of blood pressure. 2. This study was designed to examine whether more restricted periods of urine collection retained the relation to the prevailing level of blood pressure and successfully identified subjects with microalbuminura. 3. Fifty elderly subjects (aged over 60 years) made two consecutive 24-h urine collections for measurement of urinary albumin excretion, divided between daytime and night-time periods. Thirty-three subjects also provided a random ‘spot’ urine sam

APA, Harvard, Vancouver, ISO, and other styles

10

Danjou, I., J. Coquart, C. Foulon, M. C. Traisnel, S. Pieniezny, and C. Lemaire. "PP3 Evaluation d’une brochure d’information sur la microalbuminurie." Diabetes & Metabolism 36 (March 2010): A111. http://dx.doi.org/10.1016/s1262-3636(10)70453-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Marre, Michel. "La recherche de la microalbuminurie chez les diabétiques." Trait - d'Union 1, no. 4 (1986): 19–23. http://dx.doi.org/10.1016/s0980-9090(86)80069-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Halimi, Serge. "Mesure de la microalbuminurie chez les patients diabétiques." La Presse Médicale 35, no. 7-8 (2006): 1109–10. http://dx.doi.org/10.1016/s0755-4982(06)74763-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Khochtali, I., A. Baba, H. Marmouch, N. Hamza, M. Kacem, and S. Mahjoub. "P65 Tabac et microalbuminurie chez le diabétique type 2." Diabetes & Metabolism 36 (March 2010): A55. http://dx.doi.org/10.1016/s1262-3636(10)70213-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Paix, Y., E. Verlet, R. Bresson, et al. "p43 Association entre microalbuminurie (MA) et score de précarité sociale." Diabetes & Metabolism 38 (March 2012): A42. http://dx.doi.org/10.1016/s1262-3636(12)71145-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Halimi, Jean-Michel, Samy Hadjadj, Victor Aboyans, et al. "Microalbuminurie et excrétion urinaire d'albumine: recommandations pour la pratique clinique." Néphrologie & Thérapeutique 3, no. 6 (2007): 384–91. http://dx.doi.org/10.1016/j.nephro.2007.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Renaudeau, Claude, Sanae Boushain, Corinne Civadier, Franck Ceppa, and Philippe Vest. "Évaluation du test de dépistage de la microalbuminurie Servibio®." Revue Française des Laboratoires 2000, no. 325 (2000): 45–49. http://dx.doi.org/10.1016/s0338-9898(00)80521-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Dantoine, T., A. Lafarge, J. Debord, L. Merle, and J. P. Charmes. "Microalbuminurie: marqueur de la dysfonction endothéliale lors de la maladie d'Alzheimer?" La Revue de Médecine Interne 24 (December 2003): 465s. http://dx.doi.org/10.1016/s0248-8663(03)80553-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Marre, M. "Intérêt pronostique de la microalbuminurie chez l'hypertendu diabétique ou non diabétique." La Revue de Médecine Interne 12, no. 6 (1991): S282—S283. http://dx.doi.org/10.1016/s0248-8663(05)80635-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Jbira, S., L. Cherki, F. Ajdi, A. Chraïbi, and S. Abdelkarim Kadiri. "P027 - Place de la microalbuminurie dans le risque cardiovasculaire chez le diabétique." Annales d'Endocrinologie 66, no. 5 (2005): 415–16. http://dx.doi.org/10.1016/s0003-4266(05)81868-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Daunizeau, Alain. "Conditions pré-analytiques et analytiques du dosage de la microalbuminurie au laboratoire." Bio Tribune Magazine 18, no. 1 (2006): 14. http://dx.doi.org/10.1007/bf03001358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Oulad Sayad, N., A. Errajraji, and A. Diouri. "P158 Place de la microalbuminurie dans le risque cardiovasculaire chez le diabétique." Diabetes & Metabolism 34 (March 2008): H85. http://dx.doi.org/10.1016/s1262-3636(08)73070-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Bathaei, S., J. Vitry, C. Noel, A. Vambergue, C. Lemaire, and M. Romon. "P44 Évaluation des connaissances des médecins généralistes (MG) sur la microalbuminurie (MA)." Diabetes & Metabolism 38 (March 2012): A42. http://dx.doi.org/10.1016/s1262-3636(12)71146-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Elliott, T. G., J. R. Cockcroft, P. H. Groop, G. C. Viberti, and J. M. Ritter. "Inhibition of Nitric Oxide Synthesis in Forearm Vasculature of Insulin-Dependent Diabetic Patients: Blunted Vasoconstriction in Patients with Microalbuminuria." Clinical Science 85, no. 6 (1993): 687–93. http://dx.doi.org/10.1042/cs0850687.

Full text

Abstract:

1. Microalbuminuria is a risk factor for cardiovascular disease in patients with insulin-dependent diabetes mellitus, and may be a marker of microvascular dysfunction including endothelial damage. The purpose of this study was to determine whether vasoconstrictor responses to NG-monomethyl-L-arginine, an inhibitor of endothelium-derived relaxing factor/nitric oxide biosynthesis, differ between healthy subjects and insulin-dependent patients with or without microalbuminuria. 2. Twenty-eight insulin-dependent diabetic patients (14 with normal albumin excretion, 14 with microalbuminuria) were stu

APA, Harvard, Vancouver, ISO, and other styles

24

Mirić, Dijana, Bojana Kisić, Dragana Puhalo-Sladoje, et al. "Relationship between ACR and other determinants of microalbuminuria in T2DM patients." Praxis medica 49, no. 1-2 (2020): 1–6. http://dx.doi.org/10.5937/pramed2002001m.

Full text

Abstract:

Introduction: The occurrence of microalbuminuria in type 2 diabetes mellitus (T2DM) patients is regarded as an early clinical sign of incipient kidney damage. Microalbuminuria is often evaluated as urinary albumin to urinary creatinine ratio (ACR). Aim: To assess determinants of microalbuminuria in T2DM patients without prior diagnosis of nephropathy using ACR cut-off values. Materials and Methods: ACR was measured in a total of 90 T2DM patients, during two months in three non-consecutive days, and routine biochemical analyses were performed, including glycated hemoglobin (HbA1c), serum uric a

APA, Harvard, Vancouver, ISO, and other styles

25

Ekulu, P., D. Betukumesu, A. B. Nkoy, et al. "Variants génétiques d’APOL1 et risque de microalbuminurie chez les enfants congolais présumés sains." Néphrologie & Thérapeutique 14, no. 5 (2018): 411. http://dx.doi.org/10.1016/j.nephro.2018.07.364.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chafik, A., I. Azgaou, G. El Mghari, and N. El Ansari. "Association entre anomalie d’indice de pression systolique et microalbuminurie chez les patients diabétiques." Annales d'Endocrinologie 75, no. 5-6 (2014): 390. http://dx.doi.org/10.1016/j.ando.2014.07.402.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Ozcelik, Fatih, Serif Kactas, Halime Hanim Pence, et al. "Fractional excretion of magnesium as an early indicator of renal tubular damage in normotensive diabetic nephropathy." Turkish Journal of Biochemistry 45, no. 5 (2020): 543–51. http://dx.doi.org/10.1515/tjb-2019-0232.

Full text

Abstract:

AbstractObjectivesThe aim of the present study is to evaluate the diagnostic powers of fractional magnesium, sodium and potassium as markers of renal tubular damage in normotensive type 2 diabetes mellitus (T2DM) patients with respect to microalbuminuria and estimated glomerular filtration rate (eGFR).Materials and methodsForty healthy volunteers and 91 normotensive T2DM patients were included in the study. Patient group was divided into two according to albuminuria level; 49 were normoalbuminuric and 42 were microalbuminuric. In addition to albumin in urine, urine and serum Na, K, Mg and crea

APA, Harvard, Vancouver, ISO, and other styles

28

Hamrour, F. "Microalbuminurie : sommes-nous conformes à la méthode de dosage validée ? Audit auprès des laboratoires." Néphrologie & Thérapeutique 9, no. 5 (2013): 326–27. http://dx.doi.org/10.1016/j.nephro.2013.07.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Schneider, N., KM Aakre, G. Thue, S. Sandberg, V. Durlach, and P. Gillery. "Evaluation de la prescription et de l’interprétation des dosages de microalbuminurie en médecine générale." Annales de biologie clinique 67, no. 1 (2008): 047–53. http://dx.doi.org/10.1684/abc.2008.0286.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Trivin, F., and C. Couteaud. "Maîtrise des complications rénales du diabète : intérêt de la mesure de la paucialbuminurie (microalbuminurie)." Trait - d'Union 2, no. 2 (1987): 37–38. http://dx.doi.org/10.1016/s0980-9090(87)80027-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Khalaf, R., Z. Hadj Ali, Y. Htira, and F. Ben Mami. "L’insuffisance rénale en l’absence de microalbuminurie chez le diabétique : à propos de 110 cas." Annales d'Endocrinologie 81, no. 4 (2020): 449. http://dx.doi.org/10.1016/j.ando.2020.07.878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Rahman, Md Anisur, Md Mostarshid Billah, Palash Mitra, et al. "Raised Arterial Pressure and Microalbuminuria in Type 2 Diabetic Subjects with Familial Hypertension." Bangladesh Critical Care Journal 4, no. 1 (2016): 14–18. http://dx.doi.org/10.3329/bccj.v4i1.27973.

Full text

Abstract:

Background and Aims : Microalbuminuria is claimed to be an early marker of nephropathy in type 2 diabetes.The raised arterial pressure is an important factor in the progression of diabetic nephropathy. There is a significant correlation between blood pressure and the progression of albuminuria in both type 1 and type 2 diabetes. This study in Bangladeshi type 2 diabetic patients was to evaluate whether microalbuminuria and raised arterial pressure are influenced by familial predisposition to hypertension.Methods : Sixty three newly diagnosed Bangladeshi type 2 diabetic patients were investigat

APA, Harvard, Vancouver, ISO, and other styles

33

Banu, I., M. T. Nguyen, E. Cosson, and P. Valensi. "P9 Microalbuminurie et syndrome métabolique chez l’obèse non diabétique. Absence d’influence d’une dysfonction autonome cardiaque." Diabetes & Metabolism 35 (March 2009): A31. http://dx.doi.org/10.1016/s1262-3636(09)71807-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Lemaire, A., B. Alexandre, C. Lemaire, V. Fasquel, C. Foulon, and X. Lenne. "P20 Association microalbuminurie dysfonction érectile chez des hommes présentant des facteurs de risques cardio-vasculaires." Diabetes & Metabolism 36 (March 2010): A44. http://dx.doi.org/10.1016/s1262-3636(10)70168-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Paix, Y., V. Coliche, X. Lenne, et al. "P62 Précarité, Microalbuminurie (MA) et Facteurs de risque cardiovasculaire : une association à très haut risque." Diabetes & Metabolism 36 (March 2010): A54. http://dx.doi.org/10.1016/s1262-3636(10)70210-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Szymanowicz, A., E. Blanc-Bernard, C. Roche, M. J. Neyron, M. Perrin, and K. Nourdine. "Évaluation du Micral Test® en vue du dépistage de la microalbuminurie en biologie délocalisée." Immuno-analyse & Biologie Spécialisée 23, no. 2 (2008): 109–15. http://dx.doi.org/10.1016/j.immbio.2008.02.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kumar, K. Manoj, and K. M. Jeyabalaji. "Correlation of microalbuminuria with its clinical outcome in pre-hypertensives: a cross-sectional study from South India." International Journal of Advances in Medicine 8, no. 7 (2021): 887. http://dx.doi.org/10.18203/2349-3933.ijam20212307.

Full text

Abstract:

Background: Prehypertension is a major public health concern. The condition is much prevalent in India and is often associated with other cardiovascular (CV) risk factors and independently increases the risk of hypertension and subsequent cardiovascular events. Several studies have shown microalbuminuria as a sensitive marker for predicting CV risk in pre-hypertensive. The objective of this study was to assess the prevalence of microalbuminuria in prehypertension and to determine its association with electrocardiogram (ECG) and echocardiographic (Echo) parameters indicative of CV risk.Methods:

APA, Harvard, Vancouver, ISO, and other styles

38

Wahyuni, Emmy, and Imam Budiwiyono. "MIKROALBUMIN AIR KEMIH (URIN) PASIEN DM TIPE 2." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 15, no. 3 (2018): 98. http://dx.doi.org/10.24293/ijcpml.v15i3.969.

Full text

Abstract:

Diabetic Nephropathy is one of several chronic complication of type 2 DM that could lead to end stage renal disease (ESRD). In type2 DM patients, about 85% of ESRD caused by diabetic nephropathy. Persistent microalbuminuria can be predictor for nephropathy. Earlydetection of microalbuminuria could be useful in improving an aggressive treatment to avoid ESRD and other macrovasculer disorder intype 2 DM patients. The purpose of this study was to describe the microalbuminuria profile in type 2 DM patients. A cross sectional studywas taken on 21 type 2 DM patients. Data were analyzed by descriptiv

APA, Harvard, Vancouver, ISO, and other styles

39

Kutlugun, Aysun Aybal, Fatma Ayerden Ebinc, Mujgan Tek Ozturk, et al. "Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR." Romanian Journal of Internal Medicine 56, no. 1 (2018): 21–26. http://dx.doi.org/10.1515/rjim-2017-0036.

Full text

Abstract:

Abstract Aims. The aim of this study was to evaluate the association between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and microalbuminuria in patients with normal estimated glomerular filtration rate (eGFR). Methods. 174 patients who had eGFR ≥ 60 mL/min/1.73 m2 were studied. Patients were divided into two groups according to the urinary albumin excretion as microalbuminuric group (n = 105) and normoalbuminuric group (n = 69). NLR and PLR levels were calculated. Results. NLR was significantly higher (p < 0.05) in microalbuminuric patients (1.91 ± 0.70) compar

APA, Harvard, Vancouver, ISO, and other styles

40

Donders, S. H. J., F. A. T. Lustermans, and J. W. J. van Wersch. "The Effect of Microalbuminuria on Glycaemic Control, Serum Lipids and Haemostasis Parameters in Non-Insulin-Dependent Diabetes Mellitus." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 30, no. 5 (1993): 439–44. http://dx.doi.org/10.1177/000456329303000504.

Full text

Abstract:

Microalbuminuria is an important risk factor for cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM) patients although the pathogenic mechanism between microalbuminuria and cardiovascular disease has not yet been established. Microalbuminuria in insulin-dependent diabetes mellitus (IDDM) patients has been related to abnormalities in haemostasis, poor glycaemic control, disadvantageous alterations in the lipid spectrum and elevated concentrations of lipoprotein(a), another independent risk factor for cardiovascular disease. In this study the interrelations between microalb

APA, Harvard, Vancouver, ISO, and other styles

41

Hrinczenko, Borys, and Jeffrey R. Schelling. "Transient Elevations of Microalbuminuria May Represent a Marker of Systemic Vascular Injury in Sickle Cell Disease Patients." Blood 114, no. 22 (2009): 4611. http://dx.doi.org/10.1182/blood.v114.22.4611.4611.

Full text

Abstract:

Abstract Abstract 4611 Sickle cell disease (SCD) is a genetic blood disorder of hemoglobin function resulting in severe morbidity and early mortality. Hemolysis and vascular obstruction, endothelial activation and dysfunction, and inflammation, are hallmarks of this disease contributing to a chronic and progressive pathophysiology. Renal complications include hematuria, proteinuria, chronic renal insufficiency, and end stage renal disease. Several studies in SCD patients have shown that microalbuminuria may be a potential marker of progression to chronic renal disease. Also, microalbuminuria h

APA, Harvard, Vancouver, ISO, and other styles

42

Lemley, Kevin V., Derek B. Boothroyd, Kristina L. Blouch, et al. "Modeling GFR trajectories in diabetic nephropathy." American Journal of Physiology-Renal Physiology 289, no. 4 (2005): F863—F870. http://dx.doi.org/10.1152/ajprenal.00068.2004.

Full text

Abstract:

In an 8-year longitudinal study of Pima Indians with type 2 diabetes and nephropathy, we used statistical techniques that are novel and depend on minimal assumptions to compare longitudinal measurements of glomerular filtration rate (GFR). Individuals enrolled with new-onset microalbuminuria either progressed to macroalbuminuria (progressors, n = 13) or did not progress (nonprogressors, n = 13) during follow-up. Subjects with new-onset macroalbuminuria at screening were also followed ( n = 22). Patients had their GFR determined serially by urinary iothalamate clearances (average 11 clearances;

APA, Harvard, Vancouver, ISO, and other styles

43

Boutaleb, H., M. Nassib, A. Chadli, H. El Ghomari, and A. Farouqi. "P100 Microalbuminurie et complications cardiovasculaires chez les patients diabétiques et hypertendus (à propos de 120 malades)." Diabetes & Metabolism 34 (March 2008): H71. http://dx.doi.org/10.1016/s1262-3636(08)73012-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Dupuy, O., L. Bordier, E. Diop, H. Mayaudon, and B. Bauduceau. "P15 L’insuffisance rénale en l’absence de microalbuminurie chez le diabétique de type 2 : mythe ou réalité ?" Diabetes & Metabolism 35 (March 2009): A32. http://dx.doi.org/10.1016/s1262-3636(09)71813-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hassani, F. Ameziane, M. Larwanou, and H. El Ouahabi. "Dyslipidémie et néphropathie diabétique : la microalbuminurie régresse-t-elle sous statines ? À propos de 150 cas." Annales d'Endocrinologie 78, no. 4 (2017): 434. http://dx.doi.org/10.1016/j.ando.2017.07.711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Jensen, Jan Skov, Knut Borch-Johnsen, Gorm Jensen, and BO Feldt-Rasmussen. "Microalbuminuria Reflects a Generalized Transvascular Albumin Leakiness in Clinically Healthy Subjects." Clinical Science 88, no. 6 (1995): 629–33. http://dx.doi.org/10.1042/cs0880629.

Full text

Abstract:

1. In epidemiological studies microalbuminuria, i.e. slightly elevated urinary albumin excretion rate, predicts increased atherosclerotic vascular morbidity and mortality. This study aimed to test the hypothesis that microalbuminuria in clinically healthy subjects is associated with a systemic transvascular albumin leakiness. In animal experiments the outflux of albumin and lipids to the arterial wall are highly correlated, and both are elevated in atherosclerosis. 2. All participants were recruited at random from a population-based epidemiological study, where the upper decile of urinary albu

APA, Harvard, Vancouver, ISO, and other styles

47

Salih, Balqes Hisham, Shatha H.Ali, and Khalid I. Allehibi. "Serum Aldosterone Levels in Patients With Diabetic Nephropathy in Relation to Vascular Calcification." Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512) 28, no. 1 (2019): 53–63. http://dx.doi.org/10.31351/vol28iss1pp53-63.

Full text

Abstract:

Diabetic Nephropathy(DN) is a complex disease manifested by persistence microalbuminuria occurring due to the interaction between hemodynamic and metabolic pathway that activates the local renin-angiotensin-aldosterone system resulting in a decline in renal functions. This study aimed to quantify the associations between serum aldosterone concentration and fetuin- A as a marker of calcification in type 2 diabetic patients with and without microalbuminuria from one side, and study the possible relationship between aldosterone and fetuin-A with glycemic indices, serum electrolyte, renal fu

APA, Harvard, Vancouver, ISO, and other styles

48

Lozano, Jose V., Jose L. Llisterri, J. Aznar, and Josep Redon. "Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics." Nephrology Dialysis Transplantation 16, suppl_1 (2001): 85–89. http://dx.doi.org/10.1093/ndt/16.suppl_1.85.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Jin, Jonghwa, Yun Hyi Ku, Yikwon Kim, et al. "Differential Proteome Profiling Using iTRAQ in Microalbuminuric and Normoalbuminuric Type 2 Diabetic Patients." Experimental Diabetes Research 2012 (2012): 1–31. http://dx.doi.org/10.1155/2012/168602.

Full text

Abstract:

Diabetic nephropathy (DN) is a long-term complication of diabetes mellitus that leads to end-stage renal disease. Microalbuminuria is used for the early detection of diabetic renal damage, but such levels do not reflect the state of incipient DN precisely in type 2 diabetic patients because microalbuminuria develops in other diseases, necessitating more accurate biomarkers that detect incipient DN. Isobaric tags for relative and absolute quantification (iTRAQ) were used to identify urinary proteins that were differentially excreted in normoalbuminuric and microalbuminuric patients with type 2

APA, Harvard, Vancouver, ISO, and other styles

50

Ozdemır, Gülsen, Meltem Ozden, Hale Maral, Sevinc Kuskay, Pinar Cetınalp, and Ilhan Tarkun. "Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 42, no. 2 (2005): 99–104. http://dx.doi.org/10.1258/0004563053492838.

Full text

Abstract:

Background: High levels of homocysteine and oxidative stress are known to be associated with premature vascular disease in type 2 diabetes mellitus (DM). The aim of this study was to estimate homocysteine levels and oxidant-antioxidant status and to determine the relationship between them in type 2 diabetic patients with and without microalbuminuria. Methods: Fasting blood samples were obtained from 48 diabetic patients (17 with and 31 without microalbuminuria) and 20 healthy subjects. Serum total homocysteine (tHcy), plasma malondialdehyde (MDA) erythrocyte glutathione (GSH) and glutathione p

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!